Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Get CLEATUSFree Trial

Get CLEATUSFree Trial

Search

Top

360 HEALTH PLAN, INC.

UEI: YRNJQ4LUVJM1

360 HEALTH PLAN, INC. is a federal contractor, registered under UEI YRNJQ4LUVJM1. It has been awarded $344,677 across 4 federal contracts. Primary work spans Medical Laboratories. Top awarding agencies include Department Of Defense.

Contact Information

Registration and classification details

Registration

UEI Code

YRNJQ4LUVJM1

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

Department Of Defense$344.7K100%

Awards by NAICS

621511 - Medical Laboratories$344.7K100%

Awards by Agency Over Time

Awards by Place of Performance

Open opportunities in 360 HEALTH PLAN, INC.'s top NAICS codes and agencies

Clinical Laboratory Testing Services (CPT-Based)The contract obligates the provider to deliver clinical laboratory testing services in full compliance with CLIA and CAP standards, specifically for specimens sourced from military personnel, with a strict 48-hour turnaround requirement for result delivery. All testing must be billed using CPT-based coding and performed to ensure accuracy, reliability, and regulatory adherence throughout the testing lifecycle. The work is to be conducted at the designated place of performance in Flowood, Mississippi, with the contract operating under a subcontract structure and governed by the NAICS code 621511, which classifies it as a clinical laboratory service. The solicitation was posted on July 28, 2026, and responses are due by August 26, 2026, with the awarding entity being the Department of Defense through its W7NH Uspfo Activity Msang 172 office.

W7NH Uspfo Activity Msang 172

POSTED

DEADLINE

HLA Typing and Crossmatch Testing ServicesThe contract requires the performance of high-resolution HLA typing and crossmatch testing to support organ transplant donor-recipient compatibility, utilizing both molecular and serological methodologies to ensure accurate and reliable identification of human leukocyte antigens. These services are critical for minimizing transplant rejection and improving long-term graft survival, with testing procedures adhering to established clinical and laboratory standards for transplant immunology. The work must be conducted with precision and timeliness to meet the urgent timelines inherent in organ transplantation processes. The contract is classified as a subcontract under the NAICS code 621511, issued by the Department of Veterans Affairs through the 249-NETWORK Contract Office 9, with performance expected to take place in the zip code area 37212. All proposals must be submitted by the deadline of August 24, 2026, and while no set-aside provisions are specified, the solicitation is open to qualified subcontractors capable of delivering accredited, high-throughput HLA testing services. The agency has not designated a point of contact, and further details are accessible through the provided SAM.gov link.

249-NETWORK Contract Office 9 (36C249)

POSTED

DEADLINE

172 AW Lab Services IDIQThe U.S. Air Force’s 172d Airlift Wing is soliciting proposals for a five-year, firm-fixed-price Indefinite-Delivery, Indefinite-Quantity (IDIQ) contract under solicitation number W50S7H-26-R-A001 to obtain comprehensive medical laboratory testing services. This is a 100% small business set-aside with a size standard of $41.5 million, targeted at NAICS code 621511 for medical laboratories. Proposals must be submitted electronically by August 26, 2026, and must include a detailed price schedule covering all services listed in the Performance Work Statement, formatted in MS Excel or PDF. Pricing must reflect unit costs for all five years of the ordering period, and any transaction fees associated with Government Purchase Card (GPC) use must be explicitly stated—otherwise, no surcharges will be assumed. The contract will be awarded using the Best Value Trade-Off process under FAR 13.5 and Part 12, prioritizing technical capability and past performance over price, though price remains a critical component evaluated for reasonableness and balance. Technical proposals must demonstrate compliance with CLIA/CAP certifications, a clear operational plan for sample collection and turnaround times within a Sunday-through-Saturday 0730–1600 window, and confirmation that all laboratory facilities are within 30 minutes’ drive of the 172d Airlift Wing and strictly within the Jackson MSA. Orders under the resulting IDIQ will be placed using either the GPC for transactions up to $25,000 or DD Form 1155 Delivery Orders for amounts above that threshold, with electronic funds transfer processed through WAWF. GPC usage is the primary execution method for low-value orders to accelerate payment cycles, and only authorized cardholders designated by the 172d Medical Group may issue such orders. Contractors must accept both GPC and Delivery Order payment mechanisms, and all invoicing must comply with WAWF requirements, including the use of specified DoDAACs for payment routing. The evaluation process will rate technical capability as the most critical factor, with subfactors for licensing, operational capability, and geographic compliance acting as gatekeepers—failure in any one will render a proposal unacceptable. Past performance will be assessed for relevance and recency within the past three years, and price will be analyzed for total evaluated cost based on estimated volumes

W7NH Uspfo Activity Msang 172

POSTED

DEADLINE

Q515--MO - HLA Testing - 626 Tennessee Valley Healthcare System HLA Transplant Testing Services POP: 10/1/2026-9/30/2032The Department of Veterans Affairs, through Network Contracting Office 9, has issued a solicitation for HLA Transplant Testing Services to support the Tennessee Valley Healthcare System in Nashville, Tennessee. The contract has a performance period extending from October 1, 2026, through September 30, 2032, and is identified by solicitation number 36C24926R0076 under NAICS code 621511 and Product Service Code Q515. Proposals are due by August 24, 2026, with submissions to be directed to the contracting office located in Murfreesboro, Tennessee. The primary point of contact is Contract Specialist Rebecca Espinoza, reachable via email at rebecca.espinoza@va.gov. The place of performance is the Tennessee Valley Healthcare System’s facility at 1310 24th Avenue South, Nashville, TN 37212. The solicitation is for specialized clinical laboratory services critical to organ transplant compatibility assessments, though detailed specifications, deliverables, evaluation factors, pricing terms, and contractual clauses have not yet been released in the available documentation. Information regarding inspection criteria, packaging and labeling requirements, quality standards such as CLIA or CAP, invoicing procedures, accounting data, key personnel qualifications, and special requirements including security clearances or organizational conflict of interest provisions remain unspecified and are expected to be detailed in the full solicitation package when published. No set-aside status has been designated, and no attachment lists, contract clauses, or evaluation factors are currently accessible. All cost information, line-item details, and submission formatting instructions are pending release. Offerors must await the official solicitation for comprehensive guidance on compliance, technical requirements, and award methodology.

249-NETWORK Contract Office 9 (36C249)

POSTED

DEADLINE

Clinical Laboratory Testing and Specialized Biochemical AnalysisServices for the NHGRI Undiagnosed Diseases Program (UDP) through Baylor Genetics LaboratoryThe contract entails the provision of CLIA-certified clinical laboratory testing and specialized biochemical analysis services for the National Human Genome Research Institute’s Undiagnosed Diseases Program, under NIH protocol 15-HG-0130, through Baylor Genetics Laboratory. The work supports the evaluation of patients with complex, rare, and previously undiagnosed multisystem disorders, focusing on genetic, metabolic, and mitochondrial conditions. Services include advanced testing such as mitochondrial DNA copy number quantification, assessment of mitochondrial deletions, metabolomic profiling, biochemical pathway analysis, and testing of tissues including muscle, liver, fibroblasts, blood, and urine, along with follow-up family studies when authorized. All testing must adhere to federal and state regulations, using validated methodologies and maintained quality assurance systems to ensure accuracy and compliance. The contractor is required to deliver comprehensive laboratory reports with clinical interpretations and limitations within established turnaround times, using secure, privacy-compliant transmission methods. Immediate notification of critical or clinically significant findings is mandatory to support urgent patient care. Technical consultation services are essential, including guidance on test selection, specimen handling, result interpretation, and recommendations for additional testing. The contractor must also actively participate in scientific and clinical discussions as requested by NIH. The solicitation, numbered 75N98026Q00900, is issued by the National Institutes of Health within the Department of Health and Human Services, with responses due by August 7, 2026, and performance primarily based in Bethesda, Maryland.

National Institutes Of Health Olao

POSTED

DEADLINE

Clinical Chemistry Testing ServicesThe contract outlines the provision of clinical chemistry testing services to be performed on-site during operational hours, focusing on routine and specialized tests including electrolytes, liver function panels, and metabolic panels. These services are required to support medical operations at the designated place of performance in Agana Heights, Guam, with a zip code of 96910. The work falls under NAICS code 621511, which classifies it as a medical and diagnostic laboratory service, and is structured as a subcontract under the Defense Health Agency Hcd West, part of the Department of Defense. The opportunity was posted on July 27, 2026, and responses must be submitted by August 4, 2026, at 3:30 a.m. Eastern Time, with no set-aside provisions specified for small businesses or other categories. All testing must be conducted accurately and efficiently within the facility’s operational schedule to meet clinical needs.

Defense Health Agency Hcd West

POSTED

DEADLINE

Clinical Laboratory Testing Services – Microbiology & Molecular DiagnosticsThe contract requires comprehensive on-site diagnostic testing services focused on microbiology and molecular diagnostics for all patient populations, with a strict mandate that at least 90 percent of all tests be processed in-house. This includes critical procedures such as Group B Strep PCR testing, ensuring rapid, accurate, and reliable results without reliance on external laboratories. The work must be performed at the designated location in Agana Heights, Guam, with a zip code of 96910, under the oversight of the Defense Health Agency Hcd West, a division of the Department of Defense. The opportunity is structured as a subcontract and falls under the NAICS code 621511 for medical and diagnostic laboratories. The solicitation was posted on July 27, 2026, and responses are due by August 4, 2026, at 3:30 a.m. There is no set-aside classification specified, and no point of contact details are provided within the data. The requirement emphasizes operational efficiency and diagnostic fidelity, aligning with the agency’s goal to deliver timely, high-quality clinical laboratory services directly at the point of care.

Defense Health Agency Hcd West

POSTED

DEADLINE

Genotyping Analysis ServicesThe US Army Army Research Institute of Environmental Medicine is seeking a vendor to perform large-scale genomic analysis on 648 DNA samples collected as part of the Military Health and Nutrition Examination Survey, using the Illumina Global Diversity Array to genotype approximately 1.8 million genome-wide SNPs. This service supports critical research operations including population genetics, ancestry inference, polygenic score calculation, and genome-wide association studies. The contractor must deliver comprehensive technical reports with full de-identified datasets within 90 days of sample receipt, alongside a finalized Quality Control Plan within 15 days of award and same-day confirmation of sample arrival. All work must adhere to Good Laboratory Practices and validated Standard Operating Procedures, with analytical accuracy requiring zero customer complaints and a minimum genotype call rate of 96.5 percent, including HapMap controls and duplicate samples for validation. The contract is expected to be awarded on a Firm-Fixed Price basis under a trade-off evaluation process prioritizing Technical Approach and Past Performance, both of which must meet an Acceptable threshold before Price is considered. Only offers that are technically acceptable and demonstrate relevant past performance with substantial or good confidence will proceed to price evaluation. The solicitation requires electronic submission of two volumes — a 10-page Technical Approach and a separate Past Performance and Price volume — via email by 9:00 AM Eastern Time on July 30, 2026, using MS Word, Excel, or searchable PDF formats with no compression. The contractor must be registered in SAM.gov and the WAWF portal for invoicing, which will be conducted electronically following DFARS requirements. Samples must be shipped as a single batch immediately after award in EDTA tubes at 0.5 mL per sample, with delivery to the destination in Natick, Massachusetts, under FOB Destination terms. The contract period of performance runs from August 4, 2026, to August 3, 2027. Contractors must comply with numerous FAR and DFARS clauses, including protections against inverted corporations, subcontracts with excluded entities, cybersecurity requirements, and prohibitions on covered telecommunications equipment. No set-aside is designated, though small business, HUBZone, SDVOSB, WOSB, EDWOSB, and 8(a) entities may compete. The government retains inspection authority at the delivery site, and all deliverables must meet the Performance Requirements Summary and Quality Assurance Surveillance Plan standards without government oversight of daily operations. Key personnel and security clearance requirements are currently reserved, and

Defense Health Agency

POSTED

DEADLINE

Reference Laboratory MRD Testing PDXThe Department of Veterans Affairs is seeking a reference laboratory service provider to perform measurable residual disease (MRD) testing for hematologic malignancies including Multiple Myeloma, Chronic Lymphocytic Leukemia, and B-cell Acute Lymphoblastic Leukemia, primarily supporting the Portland VA Medical Center. The contract is a five-year firm-fixed price arrangement with a base year starting September 1, 2026, and four option years extending through August 31, 2031, with a total estimated value of $41.5 million. The contractor must operate a CLIA-certified and CAP-accredited laboratory using FDA-cleared methodologies to deliver clinically validated MRD test results within six business days on average, with specimen logging within 24 hours of receipt and final reports issued within 24 hours post-testing. All testing outputs must integrate seamlessly with the VA’s PALMS system and be delivered securely via vendor portal and fax, accompanied by a customer-accessible results portal. The lab must supply all collection kits and comply with DOT regulations for shipping biologic specimens, with strict labeling requirements tied to patient identification, specimen type, and collection date. Performance is subject to a Quality Assurance Surveillance Plan with a 95% target for meeting turnaround time limits and mandatory annual reporting on test usage and cost savings. The contractor is required to ensure all personnel meet stringent qualifications, including a licensed pathologist certified by the American Board of Pathology as laboratory director and CLIA-compliant certifications for all staff, with background investigations equivalent to VA employee standards. All data handling must adhere to VA security protocols, including FIPS 140-2 encryption for PHI, prohibition on unauthorized copying, immediate breach reporting to the Contracting Officer, and compliance with Title 38 restrictions on sensitive health records. Operations must occur within the United States, with no offshore processing unless specifically authorized. Subcontractors are bound by identical security and compliance obligations, and any personnel changes must be immediately reported. Invoicing is mandatory through the VA’s Electronic Invoice Presentment and Payment system using EFT; paper submissions are prohibited except under limited exceptions. The award will be made using a trade-off approach where technical capability outweighs price, with proposals evaluated based on their ability to meet clinical accuracy, timeliness, regulatory compliance, and system integration requirements. Offerors must maintain an active Unique Entity Identifier (UEI), self-certify their size status, and comply with mandatory FAR clauses on whistleblower rights, prohibitions on confidentiality agreements, and

260-NETWORK Contract Office 20 (36C260)

POSTED

DEADLINE

BPA for Medical Laboratory Testing Services at 18th Medical Group - Kadena Air Base, JapanThe contract is a Blanket Purchase Agreement (BPA) for Medical Laboratory Testing Services at the 18th Medical Group on Kadena Air Base, Japan, issued under solicitation number HT941026Q2050 by the Defense Health Agency Hcd West, Department of Defense. The BPA has a total ceiling value of $50,000 over its five-year period of performance from October 1, 2026, to September 30, 2031, and is structured as a firm-fixed-price agreement for specific laboratory tests including fungal culture and identification, TSPOT-TB testing, and antifungal drug susceptibility tests. The solicitation is unrestricted and invites full and open competition under NAICS code 621511. Contractors must submit a single PDF quotation that includes a capabilities statement addressing technical requirements from the Statement of Work, a completed Quote Sheet with firm-fixed pricing for each line item, and all required representations and certifications. Past performance and technical capability are critical evaluation factors, with technical capability serving as a mandatory pass/fail gate; failure to meet the technical threshold disqualifies a respondent. The evaluation is conducted on a best value basis with past performance carrying greater weight than price. Quote submissions are due by August 11, 2026, and must be emailed to the point of contact, April Delmendo. Performance is required on-site at the 18th Medical Group Laboratory in Building 626, Room LK08, during business hours of 7:30 a.m. to 4:30 p.m., Monday through Friday, excluding U.S. government holidays. The contractor must handle specimen collection daily within these hours, ensuring each sample includes the date, test name, patient name, and last four digits of the patient’s Social Security Number. The contractor is responsible for maintaining current laboratory accreditation, implementing a safety plan compliant with OSHA and Japan Environmental Governing Standards (JEGS), and ensuring all personnel have the necessary military base access credentials with background screening. Contractor staff must wear visible identification at all times and are prohibited from using retired or reserve military titles. Invoicing and payment will be processed electronically via the Wide Area Workflow system with specific routing and DoDAAC codes assigned. The contractor holds full liability for environmental incidents, property damage, and personnel injury, with mandatory reporting within one hour. The contract incorporates numerous FAR clauses related to cybersecurity, trafficking in persons, small

Defense Health Agency Hcd West

POSTED

DEADLINE

MARSOC: Automated Armory Collaboration Event (CE)MARSOC, in partnership with SOFWERX, is inviting U.S. industry, academia, and national laboratories to collaboratively develop a revolutionary automated armory system that eliminates manual inventory processes through a fully passive, image-based tracking solution. The initiative targets the modernization of serialized weapon and equipment accountability by replacing paper logs, handwritten forms, and RFID or radio-frequency systems with secure optical recognition and computer vision technologies. Participants are challenged to design a system that authenticates users via CAC, automatically logs equipment issuance and recovery through photographic scans, tracks item locations, and maintains tamper-proof audit trails—all without emitting any RF signals to preserve operational security. The effort is driven by the need to reduce human error, minimize administrative burden, and ensure absolute accountability in high-stakes special operations environments. The collaboration unfolds in stages: first, a mandatory submission deadline of 16 August 2026 for attendance at the in-person Collaboration Event on 17 September 2026 at SOFWERX in Florida, where stakeholders will engage directly with warfighters to refine requirements. Those unable to attend may still submit solutions by 20 October 2026 for the Assessment Event, which includes a virtual Q&A on 3 November and a downselect by 1 December. Finalists will present live demonstrations during the Assessment Event from 15 to 17 December 2026, with top-performing solutions potentially entering into non-traditional agreements under 10 U.S.C. Sections 4021, 4022, or other alternative contracting authorities such as OTAs, CRADAs, or prize competitions. Selected participants must comply with NIST SP 800-171 for handling Controlled Unclassified Information. Only U.S. persons and U.S. industry entities are eligible to participate, and success in this event may lead directly to follow-on production agreements without additional competition.

Department Of Defense

POSTED

DEADLINE

Trace Chemotherapy Waste HandlingThis contract involves the specialized handling and disposal of trace chemotherapy waste generated in oncology settings, including items such as IV bags, gloves, and gowns contaminated with cytotoxic agents. The work requires strict adherence to hazardous material protocols, with all waste destined for incineration at facilities authorized to process such materials, ensuring compliance with environmental and safety regulations. The subcontract is issued by San Diego County under NAICS code 621511 and is set to close for responses on August 8, 2026, with a posting date of July 24, 2026. Performance is expected to take place within San Diego, and the contract is not designated for any specific small business set-aside. All activities must be conducted under the highest standards of containment and regulatory oversight to protect public health and environmental integrity.

San Diego County

POSTED

DEADLINE

Drug Testing Laboratory Analysis ServicesTarrant County is seeking a subcontractor to provide forensic toxicology testing services on biological specimens including urine, blood, and hair, with strict adherence to chain-of-custody protocols, CJIS security standards, and all applicable regulatory reporting requirements. The contract falls under NAICS code 621511 and is positioned as a subcontract opportunity, with responses due by August 27, 2026. The work must ensure accurate, legally defensible results compliant with criminal justice and laboratory accreditation frameworks, though specific performance locations and point of contact details are not provided. Interested parties must engage through the designated online portal to submit proposals by the deadline.

POSTED

DEADLINE

VA NWIHCS Pathology ServiceThe Nebraska-Western Iowa Health Care System is seeking market information to plan for a five-year, fixed-price, indefinite-delivery/indefinite-quantity contract to procure comprehensive Medical Laboratory and Pathology Services, including autopsy services, for three VA facilities in Omaha, Lincoln, and Grand Island, Nebraska. The contractor will be responsible for pre-analytic processing, analysis, reporting, and interpretation of clinical and anatomical pathology specimens, while the VA retains responsibility for specimen collection, grossing (except cytology), accessioning, preservation, and storage of all slides and blocks, which must be returned to VA for permanent retention. The contract will cover all testing services listed in Attachment B, with the NAICS code 621511 and PSC Q515, and will be executed over five annual ordering periods from April 2027 through March 2032. Responses to this sources-sought announcement are required by August 3, 2026, and must be submitted via email with specific documentation, including company details, SAM registration number, small business status, completed Attachment B with CLIA certifications for every testing location, and Attachment C. Contractors must provide verified reference contracts demonstrating proven experience in collecting, transporting, testing, and reporting results from remote healthcare facilities, with full details for each contract, including verification contacts. Any subcontractors involved must submit letters of commitment and their own CLIA certifications. Failure to provide complete CLIA documentation or verified experience information may result in the government determining the contractor lacks capability, impacting potential set-aside determinations. All responders must be registered in SAM and must understand this RFI is strictly for market research and does not constitute a solicitation or binding obligation.

Network Contract Office 23 (36C263)

POSTED

DEADLINE

Background Screening and Drug Testing ServicesThe contract requires the provision of pre-employment and random drug testing along with criminal background checks for security personnel, ensuring strict adherence to SAMHSA guidelines and applicable state regulations. Services must be delivered in a timely, accurate, and compliant manner to support the integrity and safety standards of security personnel under the jurisdiction of the Louisiana Department of Children & Family Services. The solicitation is classified as a subcontract with a NAICS code of 621511 and is open for responses until August 21, 2026, with no set-aside provisions designated. Performance is expected to align with Louisiana’s specific operational and regulatory requirements, though the exact location of service delivery is not specified in the posted details.

Department of Children & Family Services

POSTED

DEADLINE

DNA Testing Laboratory ServicesThe contract requires specialized DNA parentage testing services compliant with AABB standards, ensuring accurate analysis and reporting with a minimum probability of parentage of 99.0 percent. All testing must include strict chain-of-custody procedures to maintain the integrity of samples from collection through analysis, along with secure handling and storage of biological specimens. The provider is responsible for the safe destruction of samples after testing in accordance with regulatory requirements, ensuring confidentiality and compliance throughout the entire process. Services must be delivered without compromise to accuracy, security, or documentation standards. This subcontract is issued by the County of Riverside in California under NAICS code 621511 for clinical laboratory services, with a response deadline of August 26, 2026. The solicitation is open to qualified laboratories capable of meeting rigorous accreditation and procedural benchmarks for forensic and parentage DNA testing. While no specific place of performance or point of contact is listed, bidders must be prepared to support the agency’s operational needs with reliable, auditable, and timely results, adhering to all federal and state guidelines governing genetic testing and data handling.

County of Riverside

POSTED

DEADLINE

PARENTAL DNA TESTING SERVICESThe County of Riverside, through its Purchasing & Fleet Department on behalf of the Department of Public Social Services, is soliciting qualified medical laboratory facilities accredited by the American Association of Blood Banks to provide genetic DNA parentage testing services. These services include standard DNA paternity testing and motherless case DNA testing to determine biological parentage, which is critical for establishing legal paternity in cases involving public assistance under Title IV-A of the Social Service Act or when directed by the Juvenile Court for adoption proceedings. The testing supports child welfare efforts by clarifying parental rights and responsibilities for individuals engaged in informally or formally recognized child welfare services or juvenile dependency cases. The solicitation, identified as DPARC-0683, was posted on July 23, 2026, with a response deadline of August 26, 2026. All services must be performed in California and are intended for clients referred by DPSS. Only laboratories accredited by the AABB are eligible to respond, ensuring adherence to high forensic and scientific standards. The primary point of contact for inquiries is Monica Mathis, reachable via email or phone, and additional details about the solicitation are available through the public procurement portal. The contract does not specify a set-aside designation and is open to all qualified AABB-accredited providers meeting the technical and operational requirements for DNA testing in a public social services context.

County of Riverside

POSTED

DEADLINE

URINALYSIS TESTING SERVICESThe contractor will be responsible for delivering urinalysis testing services to support the Pathways Program administered by the Neighborhood Safety and Engagement (ONSE) within the District of Columbia. The services are anticipated to begin following the forecast posting date of July 23, 2026, though specific start and end dates are not detailed. The contract does not designate a set-aside classification, nor does it specify a NAICS code, organization type, or detailed place of performance, indicating the scope is focused on the delivery of testing services without geographic or demographic restrictions outlined. No point of contact information is provided, and all performance locations remain unspecified, suggesting that the exact logistics and reporting protocols will be defined in subsequent procurement steps. The forecasting nature of this posting implies an intent to gather market interest ahead of formal solicitation.

Neighborhood Safety and Engagement (ONSE)

POSTED

DEADLINE